Skip to main content

Table 1 Baseline demographics and laboratory data of all patients and classification according to renal function

From: Mineral metabolism and outcomes in chronic kidney disease stage 2–4 patients

 

eGFR (mL/min/1.73m2)

Parameters

All Patients (n=466)

>=60 (n=67)

45-59 (n=123)

30-44 (n=161)

<=29 (n=115)

P-value a

Age (yrs)

65±13.2

61.2±15.1

62.6±13.7

66.1±12.3

68±11.6

<0.001

Male Sex (n/%)

261 (56)

60 (89.6)

90 (73.2)

75 (46.6)

36 (31.3)

<0.001

BMI (kg/m2)

25.4±4.7

25±3.9

26.6±5.2

25±4.5

24.9±4.6

0.16

Hypertension (n/%)

422 (90.6)

58 (86.6)

115 (93.5)

147 (91.3)

102 (88.7)

0.948

Dyslipidemia (n/%)

324 (69.5)

49 (73.1)

85 (69.1)

114 (70.8)

76 (66.1)

0.404

DM (n/%)

263 (56.4)

28 (41.8)

65 (52.8)

102 (63.4)

68 (59.1)

0.011

CVD (n/%)

104 (22.3)

9 (13.4)

25 (20.3)

42 (26.1)

28 (24.3)

0.967

Calcium intake (n/%)

133 (28.5)

10 (14.9)

22 (17.9)

45 (28)

56 (48.7)

<0.001

Nutritional vitamin D (n/%)

49 (10.5)

7 (10.4)

11 (8.9)

20 (12.4)

11 (9.6)

0.972

Active vitamin D (n/%)

18 (3.9)

0 (0)

1 (0.8)

4 (2.5)

13 (11.3)

<0.001

Laboratory data

      

Calcium (mg/dL)b

9.3±0.5

9.19±0.53

9.27±0.43

9.32±0.44

9.28±0.55

0.195

Phosphate (mg/dL)

3.8±0.6

3.45±0.51

3.58±0.55

3.81±0.56

4.12±0.71

<0.001

Alkaline Phosphatase (U/L)

73.4±28.6

65.5±23.6

67.8±25

78.2±27.9

79.2±34.9

0.034

PTH (pg/mL)c

66 (43–105)

40 (29–61)

58 (38–74)

70 (48–103)

117 (71–173)

<0.001

25-OH-D (ng/mL)

22±9.1

24.6±9.2

22.7±10.3

22.1±8.3

19.8±8.3

<0.001

Albumin (g/L)

37.5±5.2

38.1±6.6

39.2±4.3

37.1±5.2

36±4.8

<0.001

Cholesterol (mg/dL)

192±56

205±74

194±55

188±57

189±41

0.301

BUN (mg/dL)

29.7±14.6

16.1±4.7

22.4±6.8

29.6±9.7

45.1±16.2

<0.001

Creatinine (mg/dL)

2.25±1.21

1.23±0.16

1.62±0.34

2.12±0.49

3.68±1.53

<0.001

eGFR (mL/min/1.73 m2)

42.3±16.4

70.2±9.6

51.9±4.4

37.1±4.1

22.1±5.2

<0.001

UPCR (mg/g)c,d

0.67 (0.21-2.43)

0.24 (0.11-0.88)

0.35 (0.12-1.72)

0.58 (0.24-1.89)

1.78 (0.77-3.86)

<0.001

  1. a P-value for trend from eGFR>=60 to <=29, bcorrected calcium, cmedian (IQR), dspot urine protein/creatinine ratio.